CXV Global, Panacea Technologies Combine Forces

The transaction creates a leading global provider of automation and digitization solutions and professional services for life sciences’ operations worldwide.

Cx Vglo Logo

CXV Global, a strategic alliance comprised of European and U.S.-based Crest Solutions, Xyntek, and VistaLink, is combining the three businesses under common ownership with Philadelphia-headquartered Panacea Technologies. The transaction creates a leading global provider of automation and digitization solutions and professional services that maximize the efficiency of life sciences’ worldwide operations across product development, manufacturing, packaging, and distribution. Key features include:

  • A comprehensive portfolio of innovative automation solutions and digitization capabilities encompassing machine vision, serialization, digitization, and resourcing for R&D and manufacturing sites
  • An extensive global network anchored by a strong presence in two of the world’s largest life sciences markets: Europe and the U.S.
  • 24/7 production activity and multi-site, multi-national, and multi-lingual project support spanning 10 time zones
  • High-touch service from a global workforce of 500+ employees possessing deep technical and engineering expertise

Brendan McAtamney, newly appointed chairman of the new platform, states, “I am excited to be part of building a much-needed solution to advance the critical work of pharmaceutical and medical technology companies. The combination of CXV Global and Panacea’s innovative technologies and capabilities is unparalleled. Working with their talented leadership team, we have a tremendous opportunity to make a difference in our industry.”

Frank Madden, co-founder and chief executive officer of CXV Global, adds, “Bringing CXV Global and Panacea Technologies together under common ownership bolsters our ability to optimize and support the full scope of our clients’ product operations, from development through distribution, wherever and whenever they need.”

Abhijit C. Jog, founder and chief executive officer of Panacea Technologies, concludes, “CXV Global’s culture and commitment to serving their customers are incredibly similar to ours. Combining our life sciences expertise and world-class solutions is a natural next step toward advancing our work to meaningfully contribute to our customers’ goals for bringing new therapies to market.”


Fill out the form below to request more information about CXV Global, Panacea Technologies Combine Forces